News Features Imperfect Evidence: How Strong Is the Case for Transcatheter Tricuspid Valve Interventions? Todd Neale October 22, 2025
News Features Let’s Talk About Sex: How Best to Broach Post-MI Conversations Caitlin E. Cox June 14, 2024
News Features Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends Michael O'Riordan January 06, 2023
News Features Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI? L.A. McKeown December 02, 2022
News Features FFR’s Future: Negative Trials Spur Debate Over Technology’s Role Michael O'Riordan December 23, 2021
News Features Cath Lab Teams Find Enduring Lessons in COVID-19’s Unending Reign L.A. McKeown December 20, 2021
News Features The Hope Dealers: How Clinicians and New Tech Could End Unnecessary PAD Amputations L.A. McKeown December 24, 2020
News Features Too Easy to Misconstrue: Is It Time to Ditch Periprocedural MI? Michael O'Riordan December 02, 2020
News Features Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance Shelley Wood April 29, 2020
News Features TCAR’s Rise Is Shaking Up Carotid Stenosis, but Dependable Data Lag Behind Todd Neale January 02, 2020
News Features Year in Review: Endovascular Saw Paclitaxel Storm Rage, CLI Care Advance in 2019 L.A. McKeown December 12, 2019
News Features Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019 Todd Neale December 10, 2019
News Features Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too Michael O'Riordan December 09, 2019
News Features Survey Says: Interventional Cardiologists Still Divided Over Appropriate Use Criteria Caitlin E. Cox October 18, 2018
News Features ISCHEMIA Fracas: Amid Charges of Moving the Goalposts, Investigators Come Out Swinging Michael O'Riordan March 23, 2018
News Features Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate Michael O'Riordan November 27, 2017